Shigeru Satoh

Influence of CYP3A5 and MDR1 (ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients

Norihiko Tsuchiya, Shigeru Satoh, Hitoshi Tada et al. · Transplantation · 2004 · 251 citations

Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.

Tomonori Habuchi, Takehiro Suzuki, Ryusei Sasaki et al. · PubMed · 2000 · 183 citations

Polygenic Risk, Genetic Epidemiology, Human Polymorphism +16

Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.

Tomonori Habuchi, Toshio Suzuki, Ryuichiro Sasaki et al. · PubMed · 2000 · 158 citations

Cyp17 Gene, Urology, Cytochrome P450c17alpha Enzyme +14

Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients

Masatomo Miura, Shigeru Satoh, Kazuyuki Inoue et al. · European Journal of Clinical Pharmacology · 2007 · 149 citations

Urology, Transplantation, Kidney Transplant +12

Impact of CYP3A5 and MDR1(ABCB1) C3435T Polymorphisms on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients

Hitoshi Tada, Norihiko Tsuchiya, Shigeru Satoh et al. · Transplantation Proceedings · 2005 · 110 citations

Urology, Transplantation, Kidney Transplant +7